Patiromer With or Without Food for the Treatment of Hyperkalemia
Part of paid clinical trials in Fountain Valley, California.
- Sponsor
- Relypsa, Inc.
- Study ID
- NCT02694744
- Phase
- PHASE4
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- patiromer — DRUG8.4 g/day starting dose, administered orally
Study Details
The purpose of this study is to evaluate the efficacy and safety of patiromer administered once daily (QD) when given with food compared to without food (experimental treatment group) for the treatment of hyperkalemia (high potassium in the blood).
Key Dates
- Start date
- Feb 29, 2016
- Status verified
- May 2021
- Primary completion
- Jul 31, 2016
- Completion
- Aug 31, 2016
Study Design
- Enrollment
- 114 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Group 1 - Dosing Without FoodPatiromer dosing without food
- Active Comparator: Group 2 - Dosing With FoodPatiromer dosing with food
Primary Outcome Measure
Percentage of Subjects With Serum Potassium in the Target Range (3.8 - 5.0 mEq/L) at Either Week 3 or Week 4 [ Time Frame: 21 to 28 Days ]
Locations (29)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Investigator Site 12 | Fountain Valley | California | 92708 | - |
| Investigator Site 11 | Huntington Beach | California | 92648 | - |
| Investigator Site 38 | Palm Springs | California | 92262 | - |
| Investigator Site 20 | Riverside | California | 92505 | - |
| Investigator Site 21 | San Dimas | California | 91773 | - |
| Investigator Site 24 | Denver | Colorado | 80230 | - |
| Investigator Site 30 | Edgewater | Florida | 32132 | - |
| Investigator Site 10 | Hialeah | Florida | 33012 | - |
| Investigator Site 13 | Hollywood | Florida | 33021 | - |
| Investigator Site 16 | Lauderdale Lakes | Florida | 33319 | - |
| Investigator Site 17 | Lauderdale Lakes | Florida | 33313-1638 | - |
| Investigator Site 15 | Miami | Florida | 33015 | - |
| Investigator Site 43 | Miami | Florida | 33147 | - |
| Investigator Site 18 | Pembroke Pines | Florida | 33028 | - |
| Investigator Site 27 | Tampa | Florida | 33614 | - |
| Investigator Site 44 | Meridian | Idaho | 83642 | - |
| Investigator Site 39 | Aurora | Illinois | 60504 | - |
| Investigator Site 23 | Flint | Michigan | 48504 | - |
| Investigator Site 34 | Kansas City | Missouri | 64111 | - |
| Investigator Site 41 | Las Vegas | Nevada | 89106 | - |
| Investigator Site 37 | Flushing | New York | 11355 | - |
| Investigator Site 36 | Norman | Oklahoma | 73069 | - |
| Investigator Site 40 | Jackson | Tennessee | 38305 | - |
| Investigator Site 33 | Dallas | Texas | 75231 | - |
| Investigator Site 25 | San Antonio | Texas | 78229 | - |
| Investigator Site 26 | San Antonio | Texas | 78202 | - |
| Investigator Site 28 | San Antonio | Texas | 78215 | - |
| Investigator Site 29 | San Antonio | Texas | 78207 | - |
| Investigator Site 22 | Salt Lake City | Utah | 84124 | - |
Find similar trials in Fountain Valley, CA
Related Studies
- Patiromer for Treatment of Hyperkalaemia in Children Under 12 Years of AgePHASE2 · Recruiting · Vifor Pharma, Inc. · Aurora, Colorado
- Adding Urea to the Final Dialysis FluidPHASE1/PHASE2 · Recruiting · University of California, San Francisco · San Francisco, California
- COR-INSIGHT: Optimizing Cardiovascular and Cardiopulmonary Outcomes with AI-Driven Multiplexed Indications Using COR ECG WearableEnrolling By Invitation · Peerbridge Health, Inc · Melbourne, Florida
- AK+ Guard™ Pilot Study in Chronic Kidney Disease: Outpatient Diagnostic Accuracy and Remote MonitoringRecruiting · AccurKardia, Inc. · Eatontown, New Jersey